Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

ISIS-301012 begins phase II for familial hypercholesterolemia

Feb. 8, 2006

Androxal may restore normal testosterone level in testosterone deficient men

Feb. 7, 2006

Recently reported novel agents for obesity and lipoprotein disorders

Feb. 6, 2006

CS-917 studied in phase IIb trial for type 2 diabetes

Feb. 6, 2006

Apoxis receives orphan drug designation for APO-200

Feb. 6, 2006

The phytochemical beta-cryptoxanthin prevents bone loss in animal model

Feb. 6, 2006

Grant supports DeveloGen's development of beta-cell regeneration drugs

Feb. 6, 2006

Symphogen and Biovitrum to codevelop and commercialize SYM-001

Feb. 3, 2006

Nastech and P&G collaborate on nasal PTH1-34

Feb. 3, 2006

TP-508 promotes cartilage repair via activation of ERK1/2 MAPK

Feb. 3, 2006

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 19, 2026.
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
News in brief
BioWorld Asia
BioWorld Asia briefs for May 19, 2026
Authorities work to quickly sequence Ebola species in latest outbreak
BioWorld
If the recent hantavirus outbreak wasn’t enough to keep public health officials busy, a new Ebola virus disease outbreak has been confirmed by authorities in the...
Camp4 studies CMP-002 in SYNGAP1 haploinsufficient mouse model
BioWorld Science
Camp4 Therapeutics Corp. has highlighted new preclinical data for CMP-002, the company’s lead investigational antisense oligonucleotide (ASO) therapeutic...